Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers

PHASE4RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Pressure UlcerUlcerUlcer, PressurePressure Injury
Interventions
OTHER

ACApatch™

Participants will receive weekly applications of ACApatch™ and Standard of Care until ulcer closure, or a maximum of 20 weeks, whichever occurs first.

OTHER

caregraFT™

Participants will receive weekly applications of caregraFT™ and Standard of Care until ulcer closure, or a maximum of 20 weeks, whichever occurs first.

OTHER

Standard of Care

Beginning at the screening visit, participants will receive weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance) until ulcer closure, or a maximum of 20 weeks, whichever occurs first.

Trial Locations (1)

15146

RECRUITING

Serena Group, Monroeville

All Listed Sponsors
collaborator

ExtremityCare, LLC.

UNKNOWN

collaborator

SerenaGroup, Inc.

NETWORK

lead

Tiger Biosciences, LLC.

INDUSTRY